Testosterone in Relapsing-Remitting Multiple Sclerosis: A Case-Control Study.

J Clin Med · 2026 · PMC13302003 · PMID 42355569

Europe PMC DOI

hedged sentence

0.3680

closest p · 7.4× alpha

0.3680

boldest claim

The sentences

did not reach statistical significancep = 0.368not close (p > 0.1)

While low fT levels were more frequently observed in MS patients than in controls, this difference did not reach statistical significance (53 patients [43.7%] vs. 12 controls [34.3%]), p = 0.368). 3.3.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.